Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion type Assertion NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_head.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_provenance.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion evidence source_evidence_literature NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_provenance.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion SIO_000772 16497972 NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_provenance.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion wasDerivedFrom befree-20140225 NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_provenance.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion wasGeneratedBy ECO_0000203 NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_provenance.